(FILES) This file photo taken on October 9, 2017 shows a patient having a breast ultrasound, at the Paoli-Calmette institute, a fight against cancer regional center. AFP / ANNE-CHRISTINE POUJOULAT
Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
Women who are treated for a kind of breast cancer that is fueled by the hormone estrogen face a substantial risk of the cancer returning, even 20 years later, researchers said Wednesday.Researchers found a "steady" risk of tumors recurring over the next 15 years, up to 20 years after the initial diagnosis.Women whose original tumors were large enough to have spread to four or more lymph nodes had a 40 percent risk of a cancer recurrence over the next 15 years.For women with small, low-grade cancers and no spread to the lymph nodes, the risk of cancer recurring was 10 percent in 15 years.
FOLLOW THIS ARTICLE